Researchers are closely watching this treatment, a novel antibody targeting tau tangles , a significant hallmark of the debilitating disease . Separate from many prior attempts focused on amyloid plaques, Semorinemab aims to directly reduce these damaging tau formations in the cerebrum . Initial human data have shown signs of slightly delaying mem